Roger Crystal - 16 Sep 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Roger Crystal
Issuer symbol
N/A
Transactions as of
16 Sep 2021
Net transactions value
+$2,344
Form type
4
Filing time
16 Sep 2021, 16:12:01 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock par value $0.001 Purchase $2,344 +100 +2% $23.44 5,100 16 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.